Try our mobile app

Switch to company model in classical logic    *

General information

Country: ARGENTINA

Sector: Agricultural Inputs

Bioceres Crop Solutions Corp. engages in the provision of crop productivity solutions. The company is headquartered in Rosario, Santa Fe. The Company’s solutions include seeds, seed traits, seed treatments, biologicals, adjuvants and fertilizers. Through its subsidiary Rizobacter, it operates through Brazil and Paraguay. Through the Rizobacter brand, it produces and sells soybean biologicals.
Website: biocerescrops.com



Growth: Good revenue growth rate 92.4%, there is acceleration compared to average historical growth rates 58.4%. The revenue growth dynamics is moderately stable

Profitability: LTM EBITDA margin is positive, +9.1%. On average the margin is decreasing unsteadily. Gross margin is high, +40.6%. In the last quarter the company beat the estimated EPS. The company was ahead of estimated EPS in 20% of quarters (showing a gain of -$0.02 per share on average)

Cash Flow Generation: Dividend yield for the last twelve months 0.0%. Free cash flow yield 24.7% (LTM)

Undervaluation: Fundamental value created in LTM (estimate)


Entry Point: Share price is 28.6% higher than minimum and 24.1% lower than maximum for the last 3 years

AI Insight: the companies with similar growth trajectories, EBITDA margin, industries and geography on average are valued 5.3x by EV / Sales multiple , the company can be >100% undervalued

Key Financials (Download financials)

Ticker: BIOX
Share price, USD:  (+2.6%)12.14
year average price 12.29  


year start price 10.44 2023-05-07

min close price 9.86 2023-05-09

max close price 13.86 2024-02-12

current price 12.14 2024-05-05
Common stocks: 63 595 768

Dividend Yield:  0.0%
FCF Yield LTM: 24.7%
EV / LTM EBITDA: 20.1x
EV / EBITDA annualized: 12.9x
Last revenue growth (y/y):  92.4%
Last growth of EBITDA (y/y):  75.0%
Historical revenue growth:  58.4%
Historical growth of EBITDA:  ---
EV / Sales: 1.8x
Margin (EBITDA LTM / Revenue): 9.1%
Fundamental value created in LTM:
Market Cap ($m): 772
Net Debt ($m): -47
EV (Enterprise Value): 725
Price to Book: 2.6x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / Sales

Potential dynamics

News


2024-03-05InvestorPlace

Financial Freedom Fighters: 3 Stocks to Liberate Your Portfolio

2024-02-08Seeking Alpha

Bioceres Crop Solutions Corp. (BIOX) Q2 2024 Earnings Call Transcript

2024-01-24InvestorPlace

3 Stocks to Buy for a Sustainable Agriculture Revolution

2023-09-12Seeking Alpha

Bioceres Crop Solutions Corp. (BIOX) Q4 2023 Earnings Call Transcript
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol BIOX BIOX BIOX BIOX BIOX BIOX
reportedCurrency USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M
fillingDate 2024-02-28 2023-09-11 2023-06-30 2023-05-24 2023-02-28 2022-09-08
acceptedDate 2024-02-28 17:25:23 2023-09-11 17:29:27 2023-06-29 20:00:00 2023-05-24 16:37:31 2023-02-27 20:33:43 2022-09-08 16:41:08
calendarYear 2024.000 2024.000 2023.000 2023.000 2023.000 2023.000
period Q2 Q1 Q4 Q3 Q2 Q1
revenue 140M 116M 105M 94M 95M 127M
costOfRevenue 89M 73M 66M 36M 61M 75M
grossProfit 52M 44M 39M 57M 34M 51M
grossProfitRatio 0.367 0.375 0.368 0.614 0.357 0.405
researchAndDevelopmentExpenses 2M 5M 4M 4M 3M 4M
generalAndAdministrativeExpenses 34M 22M 0 0 0 22M
sellingAndMarketingExpenses 1M 5M 0 0 0 3M
sellingGeneralAndAdministrativeExpenses 35M 27M 3M 24M 28M 25M
otherExpenses -768 220 -1M 0 97 516 -290 487 6M
operatingExpenses 37M 39M 32M 28M 32M 35M
costAndExpenses 126M 112M 99M 64M 92M 111M
interestIncome 0 0 0 0 0 0
interestExpense 7M 7M 0 7M 10M 6M
depreciationAndAmortization -2M 5M 4M -378 145 5M 4M
ebitda 15M 9M -3M 29M 8M 21M
ebitdaratio 0.105 0.081 -0.029 0.315 0.081 0.163
operatingIncome 17M 5M 5M 30M 2M 17M
operatingIncomeRatio 0.120 0.046 0.049 0.319 0.023 0.134
totalOtherIncomeExpensesNet 2M 2M -13M -8M -10M -8M
incomeBeforeTax 10M -2M -4M 22M -8M 9M
incomeBeforeTaxRatio 0.068 -0.019 -0.042 0.238 -0.082 0.070
incomeTaxExpense 8M 429 040 -2M -5M 684 906 5M
netIncome 100 000 -5M -2M 28M -8M 4M
netIncomeRatio 0.001 -0.040 -0.016 0.301 -0.089 0.031
eps 0.002 -0.073 -0.028 0.450 -0.140 0.065
epsdiluted 0.002 -0.073 -0.027 0.450 -0.140 0.063
weightedAverageShsOut 63M 63M 62M 62M 62M 61M
weightedAverageShsOutDil 64M 63M 63M 63M 62M 62M
link Link Link Link Link
finalLink Link Link Link Link

Balance Sheet Statement

Property 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-08
symbol BIOX BIOX BIOX BIOX BIOX BIOX
reportedCurrency USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M
fillingDate 2024-02-28 2023-09-11 2023-06-30 2023-05-24 2023-02-28 2022-09-08
acceptedDate 2024-02-28 17:25:23 2023-09-11 17:29:27 2023-06-29 20:00:00 2023-05-24 16:37:31 2023-02-27 20:33:43 2022-09-08 16:41:08
calendarYear 2024.000 2024.000 2023.000 2023.000 2023.000 2023.000
period Q2 Q1 Q4 Q3 Q2 Q1
cashAndCashEquivalents 24M 28M 48M 58M 69M 47M
shortTermInvestments 17M 15M 12M 13M 19M 4M
cashAndShortTermInvestments 41M 43M 60M 71M 87M 51M
netReceivables 226M 208M 185M 198M 198M 162M
inventory 125M 139M 141M 153M 158M 143M
otherCurrentAssets 200 000 100 000 11M 0 8M 7M
totalCurrentAssets 392M 395M 397M 422M 451M 363M
propertyPlantEquipmentNet 85M 83M 82M 80M 77M 77M
goodwill 112M 112M 112M 123M 123M 123M
intangibleAssets 173M 173M 174M 174M 174M 174M
goodwillAndIntangibleAssets 285M 285M 286M 297M 297M 297M
longTermInvestments 43M 41M 40M 40M 40M 41M
taxAssets 7M 8M 7M 4M 5M 4M
otherNonCurrentAssets 6M 6M 12M 3M 3M 3M
totalNonCurrentAssets 425M 424M 421M 424M 422M 422M
otherAssets -100 000 0 0 0 0 0
totalAssets 817M 820M 818M 846M 873M 785M
accountPayables 164M 154M 146M 150M 161M 133M
shortTermDebt 118M 105M 111M 108M 108M 78M
taxPayables 900 000 6M 4M 541 935 3M 9M
deferredRevenue 24M 33M 25M 13M 44M 6M
otherCurrentLiabilities 13M 20M 16M 10M 17M 26M
totalCurrentLiabilities 318M 312M 299M 282M 331M 243M
longTermDebt 119M 135M 146M 156M 163M 165M
deferredRevenueNonCurrent 700 000 2M 2M 17M 17M 0
deferredTaxLiabilitiesNonCurrent 41M 34M 36M 47M 46M 45M
otherNonCurrentLiabilities 3M 4M 5M 10M 10M 10M
totalNonCurrentLiabilities 164M 175M 189M 230M 236M 227M
otherLiabilities 0 0 0 0 0 0
capitalLeaseObligations 14M 14M 14M 14M 14M 14M
totalLiabilities 482M 487M 488M 512M 566M 470M
preferredStock 9M 0 0 0 0 0
commonStock 6497.000 6493.000 6493.000 6436.000 6435.000 6436.000
retainedEarnings -18M -18M -14M -12M -40M -32M
accumulatedOtherComprehensiveIncomeLoss 14M 348 979 1M 2M 2M 2M
othertotalStockholdersEquity 295M 317M 312M 311M 311M 311M
totalStockholdersEquity 301M 299M 299M 301M 273M 281M
totalEquity 335M 333M 330M 334M 273M 281M
totalLiabilitiesAndStockholdersEquity 817M 820M 818M 846M 873M 785M
minorityInterest 35M 33M 32M 33M 34M 0
totalLiabilitiesAndTotalEquity 817M 820M 818M 846M 873M 785M
totalInvestments 60M 56M 52M 53M 59M 44M
totalDebt 237M 240M 257M 264M 271M 242M
netDebt 212M 212M 209M 206M 202M 195M
link Link Link Link Link Link
finalLink Link Link Link Link Link

Cash Flow Statement

Property 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol BIOX BIOX BIOX BIOX BIOX BIOX
reportedCurrency USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M
fillingDate 2024-02-28 2023-09-11 2023-06-30 2023-05-24 2023-02-28 2022-09-08
acceptedDate 2024-02-28 17:25:23 2023-09-11 17:29:27 2023-06-29 20:00:00 2023-05-24 16:37:31 2023-02-27 20:33:43 2022-09-08 16:41:08
calendarYear 2024.000 2024.000 2023.000 2023.000 2023.000 2023.000
period Q2 Q1 Q4 Q3 Q2 Q1
netIncome 108 449 -3M -3M 27M -8M 4M
depreciationAndAmortization 5M 5M 4M 5M 5M 5M
deferredIncomeTax 11M 429 040 -2M -5M 684 906 5M
stockBasedCompensation 2M 6M 734 890 617 873 2M 227 351
changeInWorkingCapital -551 139 -4M -22M -35M 29M -58M
accountsReceivables -8M -31M -16M 22M -33M -30M
inventory 14M -197 454 8M 4M -16M -7M
accountsPayables 4M 7M -759 928 -16M 30M -18M
otherWorkingCapital -11M 20M -14M -45M 49M -2M
otherNonCashItems -3M 10M 13M 9M 12M 11M
netCashProvidedByOperatingActivities 13M 15M -8M 2M 41M -32M
investmentsInPropertyPlantAndEquipment -5M -6M -7M -6M -5M -5M
acquisitionsNet 9586.000 35 682 3M 0 -2M 6M
purchasesOfInvestments -14M -3M 4M 355 426 -13M -889 342
salesMaturitiesOfInvestments 16M -35 682 -1M 2M -3M 3M
otherInvestingActivites -16M 35 682 30 202 -11 759 1363.000 117 551
netCashUsedForInvestingActivites -18M -9M -3M -3M -22M 3M
debtRepayment -11M -48M -123M -53M -39M -51M
commonStockIssued 0 0 0 0 0 0
commonStockRepurchased -277 303 -457 085 -483 160 -222 422 -2M -376 018
dividendsPaid 0 0 0 0 -264 152 -187 977
otherFinancingActivites -659 226 22M 126M 43M 42M 92M
netCashUsedProvidedByFinancingActivities 8M -27M 3M -11M 119 779 40M
effectOfForexChangesOnCash -7M 1M -1M 946 622 2M 3M
netChangeInCash -4M -20M -10M -11M 21M 14M
cashAtEndOfPeriod 24M 28M 48M 58M 69M 47M
cashAtBeginningOfPeriod 28M 48M 58M 69M 47M 33M
operatingCashFlow 13M 15M -8M 2M 41M -32M
capitalExpenditure -5M -6M -7M -6M -5M -5M
freeCashFlow 9M 9M -15M -4M 36M -37M
link Link Link Link Link
finalLink Link Link Link Link

Earning call transcript

2023 q4
2024-02-08 ET (fiscal 2024 q2)
2023 q3
2023-11-14 ET (fiscal 2024 q1)
2023 q2
2023-09-12 ET (fiscal 2023 q4)
2023 q1
2023-05-11 ET (fiscal 2023 q3)
2022 q4
2023-02-09 ET (fiscal 2023 q2)
2022 q3
2022-11-13 ET (fiscal 2023 q1)
2022 q2
2022-09-08 ET (fiscal 2022 q4)
2022 q1
2022-05-11 ET (fiscal 2022 q1)
2021 q4
2022-02-10 ET (fiscal 2022 q2)

Press-releases

Show financial reports only

2024-02-08 21:01 ET
Bioceres Crop Solutions Reports Fiscal Second Quarter 2024 Financial and Operational Results
2024-01-25 13:30 ET
Bioceres Crop Solutions to Host Fiscal Second Quarter 2024 Financial Results Conference Call on Thursday, February 8, 2024 at 4:30 p.m. Eastern Time
2024-01-23 21:30 ET
Bioceres Crop Solutions Releases Scope 1 & 2 Greenhouse Gas Emissions Report
2023-11-13 23:21 ET
Bioceres Crop Solutions Reports Fiscal First Quarter 2024 Financial and Operational Results
2023-10-31 12:30 ET
Bioceres Crop Solutions to Host Fiscal First Quarter 2024 Financial Results Conference Call on Tuesday, November 14, 2023 at 8:30 a.m. Eastern Time
2023-10-17 12:00 ET
Moolec Science Announces Capital Raise With Strategic Investors for ~US $30 Million
2023-10-17 12:00 ET
Moolec Science Announces ~US $30 Million Capital Raise With Strategic Investors
2023-09-11 20:02 ET
Bioceres Crop Solutions Reports Fiscal Fourth Quarter and Full Year 2023 Financial and Operational Results
2023-08-30 12:30 ET
Bioceres Crop Solutions to Host Fiscal Fourth Quarter and Full Year 2023 Financial Results Conference Call on Monday, September 11, 2023 at 4:30 p.m. Eastern Time
2023-07-18 11:00 ET
Corteva Agriscience and Bioceres Crop Solutions to Advance Availability of Biologicals in Europe
2023-05-10 22:00 ET
Bioceres Crop Solutions Reports Fiscal Third Quarter 2023 Financial and Operational Results
2023-04-27 11:00 ET
Bioceres Crop Solutions to Host Fiscal Third Quarter 2023 Financial Results Conference Call on Thursday, May 11, 2023 at 8:30 a.m. Eastern Time
2023-04-03 21:00 ET
Bioceres Crop Solutions Releases FY22 Sustainability Report
2023-03-07 22:00 ET
Bioceres Crop Solutions to Participate in the 35th Annual Roth Conference
2023-03-03 13:00 ET
Bioceres Crop Solutions Announces Brazil´s Regulatory Approval of Drought Tolerant HB4® Wheat for Commercialization and Cultivation
2023-02-09 01:32 ET
Bioceres Crop Solutions Reports Fiscal Second Quarter 2023 Financial and Operational Results
2023-01-26 12:00 ET
Bioceres Crop Solutions to Host Fiscal Second Quarter 2023 Financial Results Conference Call on Thursday, February 9, 2023 at 8:30 a.m. Eastern Time
2022-11-10 00:08 ET
Bioceres Crop Solutions Reports Fiscal First Quarter 2023 Financial and Operational Results
2022-10-27 11:00 ET
Bioceres Crop Solutions to Host Fiscal First Quarter 2023 Financial Results Conference Call on Thursday, November 10, 2022 at 8:30 a.m. Eastern Time
2022-09-16 11:00 ET
Syngenta Seedcare and Bioceres Crop Solutions collaborate to bring innovative biological seed treatments to market
2022-09-08 10:00 ET
Bioceres Crop Solutions Reports Fiscal Fourth Quarter and Full-Year 2022 Financial and Operational Results
2022-08-23 12:31 ET
Bioceres Crop Solutions to Host Fiscal Fourth Quarter and Full Year 2022 Financial Results Conference Call on Thursday, September 8, 2022 at 8:30 a.m. Eastern Time
2022-08-09 12:30 ET
Bioceres Crop Solutions Executed Previously Announced Financing Agreements for a Total Amount of $79 Million
2022-07-26 12:31 ET
Bioceres Crop Solutions to Participate in the Canaccord Genuity 42nd Annual Growth Conference
2022-07-12 20:43 ET
Bioceres Crop Solutions Completes Merger With Marrone Bio, Creating a Global Leader in Sustainable Agricultural Solutions
2022-06-27 12:31 ET
FDA Favorably Concludes HB4® Wheat Food and Feed Safety Evaluation
2022-06-09 12:31 ET
Bioceres Crop Solutions to Participate at ROTH 8th Annual London Conference June 21-23, 2022
2022-05-12 10:00 ET
Bioceres Crop Solutions Reports Fiscal Third Quarter 2022 Financial and Operational Results
2022-05-02 12:31 ET
Bioceres Crop Solutions to Host Fiscal Third Quarter 2022 Financial Results Conference Call on Thursday, May 12, 2022 at 8:30 a.m. Eastern Time
2022-04-29 18:00 ET
Bioceres Crop Solutions Announces Regulatory Approval of HB4® Soy in China
2022-03-16 21:58 ET
Bioceres Crop Solutions and Marrone Bio Announce Merger Agreement
2022-03-04 13:31 ET
Bioceres Crop Solutions to Attend the 34th Annual ROTH Conference March 13-15, 2022
2022-02-10 11:00 ET
Bioceres Crop Solutions Reports Fiscal Second Quarter 2022 Financial and Operational Results
2022-01-20 13:31 ET
Bioceres Crop Solutions to Host Fiscal Second Quarter 2022 Financial Results Conference Call on Thursday, February 10, 2022 at 8:30 a.m. Eastern Time
2021-12-23 13:31 ET
Bioceres Crop Solutions Subsidiary Rizobacter Completes $20 Million Offering of Series VII Corporate Bonds
2021-11-12 18:34 ET
Bioceres Crop Solutions to Participate in Upcoming Investor Conferences
2021-11-11 19:07 ET
Bioceres Crop Solutions Announces Regulatory Approval of Drought Tolerant HB4® Wheat by Brazil’s CTNBio
2021-11-10 11:00 ET
Bioceres Crop Solutions Reports Fiscal First Quarter 2022 Financial and Operational Results
2021-10-25 12:31 ET
Bioceres Crop Solutions to Host Fiscal First Quarter 2022 Financial Results Conference Call on Wednesday, November 10, 2021 at 8:30 a.m. Eastern Time
2021-09-10 12:31 ET
Bioceres Crop Solutions to Present at Lake Street’s 5th Annual Best Ideas Growth (BIG5) Conference September 14-15, 2021
2021-09-09 10:00 ET
Bioceres Crop Solutions Reports Fiscal Fourth Quarter and Full-Year 2021 Operational and Financial Results
2021-09-03 12:31 ET
Bioceres Crop Solutions Subsidiary Rizobacter Completes $16.1 Million Offering of Series VI Corporate Bonds
2021-08-19 12:31 ET
Bioceres Crop Solutions to Host Fiscal Fourth Quarter and Full Year 2021 Financial Results Conference Call on Thursday, September 9, 2021 at 8:30 a.m. Eastern Time
2021-07-19 12:31 ET
Bioceres Crop Solutions to Participate in the Jefferies 2021 Industrials Conference
2021-07-12 12:00 ET
Rizobacter and Marrone Bio Innovations Expand Strategic Alliance to Supply Novel Seed Treatment in Brazil
2021-06-16 12:41 ET
PlantArcBio announces collaboration agreement with Bioceres Crop Solutions to develop improved biomass & drought tolerant Alfalfa
2021-06-07 12:31 ET
Bioceres Crop Solutions to Participate in the 7th Annual Roth Virtual London Conference
2021-06-01 12:31 ET
Bioceres Crop Solutions Receives Approval of HB4® Drought Tolerant Soybean in Canada
2021-05-13 10:00 ET
Bioceres Crop Solutions Reports Fiscal Third Quarter 2021 Operational and Financial Results
2021-05-10 12:31 ET
Bioceres Crop Solutions Announces Agreement with Havanna to Offer Consumers HB4 Wheat-Based Sustainable Products
2021-04-26 20:01 ET
Bioceres Crop Solutions to Ring Nasdaq Stock Market Opening Bell on April 27, 2021
2021-04-22 12:31 ET
Bioceres Crop Solutions to Host Fiscal Third Quarter 2021 Financial Results Conference Call on Thursday, May 13, 2021 at 8:30 a.m. Eastern Time
2021-04-14 12:30 ET
Bioceres Crop Solutions Announces Transfer to Nasdaq Stock Market
2021-03-16 13:23 ET
Bioceres Crop Solutions Acquires Stake in Moolec Science and Enters Fast Growing Alternative Food Market
2021-03-11 13:31 ET
Bioceres Crop Solutions to Present at Upcoming March Investor Conferences
2021-03-04 21:05 ET
Bioceres Crop Solutions Subsidiary Rizobacter Argentina S.A. Completes $26.0 Million Offering of Series V Corporate Bonds
2021-02-11 12:00 ET
Bioceres Crop Solutions Reports Fiscal Second Quarter 2021 Operational and Financial Results
2021-02-02 13:31 ET
Bioceres Crop Solutions Enters Agreement with Nature Source Improved Plants to Establish Advanced HB4® Soybean Breeding Program in the United States
2021-01-28 13:31 ET
Bioceres Crop Solutions to Host Fiscal Second Quarter 2021 Financial Results Conference Call on Thursday, February 11, 2021 at 8:30 a.m. Eastern Time
2020-11-12 12:30 ET
 Bioceres Crop Solutions Corp. Reports Fiscal First Quarter 2021 Financial and Operating Results
2020-11-12 12:28 ET
Bioceres Crop Solutions Corp. Acquires full Ownership of HB4® Soy and Strategic Intellectual Property Rights for Wheat
2020-11-05 17:10 ET
Bioceres Crop Solutions Corp. Announces Upcoming Participation at Morgan Stanley Investor Conference
2020-11-03 13:00 ET
Bioceres Crop Solutions Corp. Announces Date of Fiscal First Quarter 2021 Earnings Release, Conference Call and Webcast
2020-10-08 11:30 ET
Bioceres Crop Solutions Corp. Announces Regulatory Approval of Drought Tolerant HB4® Wheat in Argentina
2020-09-15 12:31 ET
Rizobacter and Marrone Bio Innovations form a Strategic Alliance to Deploy Novel Plant Health and Crop Nutrition Technology in South America
2020-09-10 10:00 ET
Bioceres Crop Solutions Corp. Reports Fiscal Fourth Quarter and Full-Year 2020 Financial and Operating Results
2020-08-28 13:00 ET
Bioceres Crop Solutions Corp. Announces Date of Fiscal Fourth Quarter 2020 Earnings Release, Conference Call and Webcast
2020-08-27 16:00 ET
Bioceres Crop Solutions Corp. Announces Upcoming Participation at LD 500 Conference
2020-08-25 13:00 ET
Bioceres Crop Solutions Corp. Announces Successful Completion of Offer to Exchange Outstanding Warrants
2020-08-13 14:30 ET
Bioceres Crop Solutions Subsidiary Rizobacter Argentina S.A. Completes $17.0 Million Offering of Series IV Corporate Bonds
2020-07-27 23:50 ET
Bioceres Crop Solutions Corp. Announces Offer to Exchange Its Outstanding Warrants
2020-06-15 13:20 ET
Bioceres Crop Solutions Subsidiary Rizobacter Argentina S.A. Completes $15 Million Offering of Series III Corporate Bonds
2020-06-05 12:30 ET
Credit Ratings of Rizobacter Argentina SA, a Bioceres Crop Solutions Subsidiary, Raised to A- from BBB+ by Fitch Ratings Affiliate FIX SCR
2020-05-12 10:00 ET
Bioceres Crop Solutions Corp. Reports Fiscal Third Quarter 2020 Financial Results
2020-05-05 21:35 ET
Bioceres Crop Solutions Corp. Announces Date of Fiscal Third Quarter 2020 Earnings Release, Conference Call and Webcast
2020-03-09 12:30 ET
Bioceres Crop Solutions Corp. Closes Financing to Accelerate Global Launch of HB4® Technology
2020-03-04 19:00 ET
Bioceres Crop Solutions Corp. Announces Upcoming Participation at the Roth Conference
2020-02-19 16:05 ET
Bioceres Crop Solutions Corp. Announces Upcoming Participation at Bank of America Merrill Lynch Investor Conference
2020-02-11 11:00 ET
Bioceres Crop Solutions Corp. Reports Fiscal Second Quarter 2020 Financial Results
2020-01-28 16:00 ET
Bioceres Crop Solutions Corp. Announces Date of Fiscal Second Quarter 2020 Earnings Release, Conference Call and Webcast
2019-11-12 13:00 ET
Approval of HB4® Drought and Herbicide Tolerant Soybeans in Paraguay
2019-11-11 13:00 ET
Bioceres Crop Solutions Corp. Reports Fiscal First Quarter 2020 Financial Results

SEC forms

Show financial reports only

SEC form 6
2024-02-28 00:00 ET
Bioceres Crop Solutions published news for 2023 q4
SEC form 6
2024-02-28 00:00 ET
Bioceres Crop Solutions published news for 2023 q4
SEC form 6
2023-11-29 00:00 ET
Bioceres Crop Solutions published news for 2023 q3
SEC form 6
2023-11-13 21:04 ET
Bioceres Crop Solutions published news for 2023 q3
SEC form 6
2023-10-12 16:28 ET
Bioceres Crop Solutions published news for 2023 q3
SEC form 6
2023-10-11 12:15 ET
Bioceres Crop Solutions published news for 2023 q3
SEC form 6
2023-09-29 16:25 ET
Bioceres Crop Solutions reported for 2023 q2
SEC form 6
2023-09-11 17:29 ET
Bioceres Crop Solutions published news for 2023 q2
SEC form 6
2023-07-18 16:25 ET
Bioceres Crop Solutions published news for 2023 q2
SEC form 6
2023-05-24 00:00 ET
Bioceres Crop Solutions published news for 2023 q1
SEC form 6
2023-05-10 19:22 ET
Bioceres Crop Solutions reported for 2023 q1
SEC form 6
2023-04-05 06:27 ET
Bioceres Crop Solutions published news for 2023 q1
SEC form 6
2023-03-27 16:07 ET
Bioceres Crop Solutions published news for 2022 q4
SEC form 6
2023-02-28 00:00 ET
Bioceres Crop Solutions published news for 2022 q4
SEC form 6
2022-02-25 00:00 ET
Bioceres Crop Solutions published news for 2021 q4